Clinical Trial Update: Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder [Phase 3]

View source ↗

Summary

Beeline is a Phase 3 clinical trial for GRIN-related Neurodevelopmental Disorder, sponsored by GRIN Therapeutics, Inc., and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Grin-related Neurodevelopmental Disorder

Snippet

Sponsor: GRIN Therapeutics, Inc. | Conditions: GRIN-related Neurodevelopmental Disorder | Phase 3 | Status: RECRUITING